Evotec, SiREEN small molecule deal

Drug discovery and development play SiREEN (Martinsried, Germany) will select targets for which Evotec (NMarkt:EVT) will develop biological assays and identify interacting chemical scaffolds through screening of its lead discovery library. The deal covers 4 targets over the next 3 years. SiREEN will pay service fees and grant EVT access to SiREEN's drug discovery technologies over the next three years. The companies have an option to expand the deal. ...